Institute of Medicine Report Criticizes Quality of Cancer Care

Publication
Article
OncologyONCOLOGY Vol 13 No 6
Volume 13
Issue 6

There are serious shortcomings in the quality of care for manyAmericans with cancer, according to a report just released by the Institute of Medicine National Cancer Policy Board. Deficits in care identified in the report include underuse of screening

There are serious shortcomings in the quality of care for manyAmericans with cancer, according to a report just released by the Institute of Medicine National Cancer Policy Board. Deficits in care identified in the report include underuse of screening tests, lack of adherence to standards for diagnosis, inadequate patient counseling regarding treatment options, and underuse of radiation therapy and adjuvant chemotherapy after surgery. Joseph Simone, MD, medical director, Huntsman Cancer Foundation and Institute, which is affiliated with the University of Utah, headed the board that prepared the report.

The board recommended that patients who need complicated cancer surgery or chemotherapy be treated at facilities that perform a high volume of these procedures. Such procedures include removal of all or part of the esophagus, surgery for pancreatic cancer, removal of pelvic organs, and complex chemotherapy treatments. Survival rates immediately following these procedures are two to three times higher when done in more experienced facilities, according to several studies reviewed in this report.

Improving cancer care in all settings will require new efforts to track the quality of individual health plans, and to hold providers and insurers accountable. The prepublication version of the report can be downloaded from www.nap.edu.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content